Encompass Health Corporation (EHC)
Birmingham, AL, US
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, neurological disorders, cardiac and pulmonary issues, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment primarily serves the Southeast and Texas regions. Within this segment, home health services encompass a variety of Medicare-certified care options for adult patients, including skilled nursing, medical social work, home health aide assistance, and various therapies like physical, occupational, and speech therapy. Hospice services, on the other hand, provide in-home comfort and support for terminally ill patients and their families. As of June 1, 2022, Encompass Health maintained a substantial network, managing 149 hospitals, 252 home health locations, and 99 hospice locations spread across 42 U.S. states and Puerto Rico. The company, which established its roots in 1983 and is headquartered in Birmingham, Alabama, was formerly known as HealthSouth Corporation until its name change to Encompass Health Corporation in January 2018.
Based on only 1 article — low confidence
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Ballas | — | 1995-03-08 | View |
| SSCI | — | 1995-09-28 | View |
| Stellus Capital Investment Corporation 5.75% NT 2022 | SCA | 1995-12-12 | View |
| Advantage | — | 1996-02-09 | View |
| Invesco S&P SmallCap Materials ETF | PSCM | 1996-07-19 | View |
| FSSCI | — | 1996-09-16 | View |
| ReadiCare | — | 1996-10-23 | View |
| Hill-Rom Holdings, Inc. | HRC | 1997-09-25 | View |
| EHH | EHH | 2016-01-29 | View |
Index membership
| Index | Added | Removed | Status |
|---|---|---|---|
| S&P 500 | 1997-01-07 | — | Active |
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +7.48% | +5.82% | +2.22% | +13.90% | -7.40% | +1.26% | -7.59% | +70.87% | +60.08% | +230.91% | +2,446.92% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 11 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
153.00
+42.3%
|
| Last Year | 4 |
148.25
+37.9%
|
| All Time | 14 |
112.64
+4.8%
|
-
Revenue growth Medical - Care Facilities: +10.2%+10.5% ★ Q1'26: +9.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+24.2% ★ Q1'26: +30.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+12.9% Q1'26: -8.9% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+18.1% ★ Q1'26: +19.0% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+14.7% ★ Q1'26: +16.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: -1.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.93× Q1'26: 1.79× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 9 Rev. Ana. 8 EPS Ana. |
Dec 2027 9 Rev. Ana. 8 EPS Ana. |
Dec 2028 5 Rev. Ana. 2 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.86B
est: 1.85B (+0.4%)
|
2.01B
est: 2.24B (-10.3%)
|
2.13B
est: 1.78B (+19.8%)
|
2.25B
est: 1.89B (+19.1%)
|
2.37B
est: 2.32B (+2.2%)
|
3.12B
est: 3.14B (-0.8%)
|
3.64B
est: 3.71B (-1.8%)
|
3.91B
est: 3.96B (-1.1%)
|
4.28B
est: 4.27B (+0.1%)
|
4.61B
est: 4.60B (+0.2%)
|
3.57B
est: 4.64B (-23.1%)
|
4.01B
est: 5.11B (-21.4%)
|
4.35B
est: 4.33B (+0.3%)
|
4.80B
est: 5.07B (-5.3%)
|
5.37B
est: 5.35B (+0.4%)
|
5.94B
est: 5.93B (+0.1%)
|
6.42B
6.40B – 6.43B
+8.3% YoY
|
6.94B
6.90B – 7.00B
+8.1% YoY
|
7.45B
7.45B – 7.46B
+7.3% YoY
|
7.94B
7.90B – 7.98B
+6.5% YoY
|
| EBITDA |
388.60M
est: 356.45M (+9.0%)
|
441.10M
est: 325.22M (+35.6%)
|
516.60M
est: 305.98M (+68.8%)
|
590.30M
est: 429.99M (+37.3%)
|
603.80M
est: 521.84M (+15.7%)
|
678.20M
est: 647.83M (+4.7%)
|
826.70M
est: 660.83M (+25.1%)
|
834.60M
est: 714.66M (+16.8%)
|
840.20M
est: 660.55M (+27.2%)
|
940.70M
est: 781.97M (+20.3%)
|
739.60M
est: 810.72M (-8.8%)
|
888.90M
est: 887.03M (+0.2%)
|
870.10M
est: 972.17M (-10.5%)
|
1.01B
est: 1.10B (-8.9%)
|
1.19B
est: 1.16B (+1.9%)
|
1.40B
est: 1.29B (+8.8%)
|
1.40B
1.39B – 1.40B
+8.3% YoY
|
1.51B
1.50B – 1.52B
+8.1% YoY
|
1.62B
1.62B – 1.62B
+7.3% YoY
|
1.73B
1.72B – 1.74B
+6.5% YoY
|
| EBIT |
315.50M
est: 334.99M (-5.8%)
|
362.30M
est: 492.63M (-26.5%)
|
434.10M
est: 327.34M (+32.6%)
|
495.60M
est: 371.13M (+33.5%)
|
496.10M
est: 446.34M (+11.1%)
|
538.50M
est: 590.97M (-8.9%)
|
654.10M
est: 567.05M (+15.4%)
|
650.80M
est: 614.54M (+5.9%)
|
640.50M
est: 598.70M (+7.0%)
|
722.00M
est: 633.84M (+13.9%)
|
536.60M
est: 638.83M (-16.0%)
|
669.30M
est: 732.93M (-8.7%)
|
626.50M
est: 788.48M (-20.5%)
|
731.80M
est: 821.08M (-10.9%)
|
887.00M
est: 866.17M (+2.4%)
|
1.08B
est: 960.20M (+12.1%)
|
1.04B
1.04B – 1.04B
+8.3% YoY
|
1.12B
1.12B – 1.13B
+8.1% YoY
|
1.21B
1.21B – 1.21B
+7.3% YoY
|
1.28B
1.28B – 1.29B
+6.5% YoY
|
| Net Income |
899.00M
est: 983.54M (-8.6%)
|
208.70M
est: 175.16M (+19.1%)
|
185.00M
est: 145.63M (+27.0%)
|
323.60M
est: 255.72M (+26.5%)
|
222.00M
est: 208.81M (+6.3%)
|
183.10M
est: 195.85M (-6.5%)
|
247.60M
est: 216.21M (+14.5%)
|
271.10M
est: 242.71M (+11.7%)
|
292.30M
est: 250.03M (+16.9%)
|
358.70M
est: 326.73M (+9.8%)
|
284.20M
est: 277.82M (+2.3%)
|
412.20M
est: 373.96M (+10.2%)
|
271.00M
est: 357.01M (-24.1%)
|
352.00M
est: 419.71M (-16.1%)
|
455.70M
est: 440.30M (+3.5%)
|
566.20M
est: 543.72M (+4.1%)
|
612.71M
563.84M – 618.17M
+12.7% YoY
|
670.91M
617.58M – 681.61M
+9.5% YoY
|
732.28M
719.18M – 745.37M
+9.1% YoY
|
785.92M
781.43M – 792.10M
+7.3% YoY
|
| SGA |
1.09B
est: 991.15M (+10.0%)
|
1.16B
est: 1.15B (+1.1%)
|
1.23B
est: 988.13M (+24.8%)
|
1.27B
est: 1.02B (+23.7%)
|
1.34B
est: 1.29B (+3.5%)
|
1.86B
est: 1.99B (-6.3%)
|
2.19B
est: 1.92B (+14.4%)
|
2.40B
est: 2.27B (+5.6%)
|
2.65B
est: 2.34B (+13.4%)
|
2.90B
est: 2.67B (+8.7%)
|
2.12B
est: 2.95B (-28.2%)
|
228.50M
est: 2.92B (-92.2%)
|
209.00M
est: 3.62B (-94.2%)
|
258.00M
est: 794.14M (-67.5%)
|
266.50M
est: 837.75M (-68.2%)
|
3.41B
est: 928.70M (+267.3%)
|
1.01B
1.00B – 1.01B
+8.3% YoY
|
1.09B
1.08B – 1.10B
+8.1% YoY
|
1.17B
1.17B – 1.17B
+7.3% YoY
|
1.24B
1.24B – 1.25B
+6.5% YoY
|
| EPS |
9.41
est: 1.64 (+473.8%)
|
1.91
est: 0.91 (+109.9%)
|
1.67
est: 1.10 (+51.8%)
|
2.58
est: 1.35 (+91.1%)
|
2.46
est: 1.86 (+32.3%)
|
2.02
est: 1.99 (+1.6%)
|
2.77
est: 2.56 (+8.1%)
|
2.73
est: 2.72 (+0.3%)
|
2.99
est: 3.63 (-17.6%)
|
3.65
est: 3.89 (-6.3%)
|
2.87
est: 2.82 (+1.7%)
|
4.15
est: 4.30 (-3.6%)
|
2.72
est: 2.80 (-2.8%)
|
3.54
est: 4.10 (-13.7%)
|
4.53
est: 4.30 (+5.4%)
|
5.62
est: 5.31 (+5.8%)
|
5.93
5.52 – 6.05
+11.6% YoY
|
6.49
6.04 – 6.67
+9.4% YoY
|
7.17
7.04 – 7.29
+10.4% YoY
|
7.69
7.65 – 7.75
+7.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 2/5 |
| 2026-04-29 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Ownership Overview
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Group Holdings LLP | 10.52M | 10.58% | — | 9.68M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 2 | Wellington Investment Advisors Holdings LLP | 10.52M | 10.58% | — | 9.68M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 3 | Wellington Management Group LLP | 10.52M | 10.58% | — | 9.68M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 4 | Wellington Management Company LLP | 9.63M | 9.68% | — | 9.34M | — | — | IA | Delaware | 2022-02-04 | ↗ |
| 5 | (1) BlackRock, Inc. | 9.35M | 9.50% | 8.97M | — | 9.35M | — | HC | Delaware | 2019-02-04 | ↗ |
| 6 | Edward C. Johnson 3d | 9.01M | 9.54% | — | — | 9.01M | — | IN | Delaware | 2010-09-10 | ↗ |
| 7 | FMR LLC | 9.01M | 9.54% | 3.10M | — | 9.01M | — | HC | Delaware | 2010-09-10 | ↗ |
| 8 | The Vanguard Group - 23-1945930 | 9.00M | 9.05% | — | 71.4K | 8.85M | 152.0K | IA | Pennsylvania | 2021-02-10 | ↗ |
| 9 | 52-0556948 | 8.42M | 9.00% | 1.45M | — | 8.42M | — | IA | MARYLAND | 2010-02-12 | ↗ |
| 10 | BlackRock for purposes of Schedule 13G filings. | 8.16M | 8.68% | 8.16M | — | 8.16M | — | HC | Delaware | 2010-01-29 | ↗ |
| 11 | GLENVIEW CAPITAL MANAGEMENT, LLC | 6.82M | 7.46% | — | 6.82M | — | — | OO | Delaware | 2016-02-16 | ↗ |
| 12 | LARRY ROBBINS | 6.82M | 7.46% | — | 6.82M | — | — | HC, IN | United States of America | 2016-02-16 | ↗ |
| 13 | Highbridge Capital Management, LLC | 6.41M | 6.67% | — | 6.41M | — | — | IA, OO | State of Delaware | 2017-02-14 | ↗ |
| 14 | LAWRENCE M. ROBBINS | 5.90M | 6.46% | — | 5.90M | — | — | HC, IN | Delaware | 2015-07-31 | ↗ |
| 15 | Morgan Stanley | 5.79M | 6.20% | 5.75M | — | 5.79M | — | HC, CO | The state of organization is Delaware. | 2010-02-12 | ↗ |
| 16 | 98-0557567 | 5.37M | 5.30% | 5.16M | — | 5.36M | — | IA, HC | Bermuda | 2024-11-08 | ↗ |
| 17 | William Blair & Company, LLC | 5.31M | 5.55% | 5.31M | — | 5.31M | — | BD, IA | 222 W. ADAMS STREET, CHICAGO, IL 60606 USA | 2013-02-04 | ↗ |
| 18 | William Blair Investment Management, LLC | 5.22M | 5.20% | 4.57M | — | 5.22M | — | IA | Delaware | 2024-02-12 | ↗ |
| 19 | 04-2683227 | 5.21M | 5.59% | — | 4.21M | — | — | IA | Massachusetts | 2010-02-12 | ↗ |
| 20 | John S. Osterweis | 4.45M | 4.71% | — | — | — | — | HC, IN | California | 2011-02-15 | ↗ |
| 21 | BLAIR WILLIAM & CO/IL | 3.72M | 4.26% | 3.72M | — | 3.72M | — | BD, IA | W Adams Chicago IL | 2014-02-06 | ↗ |
| 22 | Osterweis Capital Management, LLC | 2.64M | 2.79% | — | — | — | — | IA | California | 2011-02-15 | ↗ |
| 23 | Jonathon S. Jacobson | 1.81M | 2.00% | 1.81M | — | 1.81M | — | IN | United States | 2009-02-17 | ↗ |
| 24 | Estate of Albert W. Ondis | 1.60M | 21.50% | 6.43M | — | 6.53M | — | OO | Invesco Ltd. – Bermuda | 2014-02-10 | ↗ |
| 25 | Capital Management, LLC | — | 0.00% | — | — | — | — | OO | State of Delaware | 2018-02-14 | ↗ |
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 400.2K +400.2K (+100.0%) | 42.48B +42.5B (+100.0%) | 0.40% +0.398 pp | 0.06% +0.064 pp | USD106.14 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 10.31M +433.6K (+4.4%) | 1.09B -160.2M (-12.8%) | 10.26% +0.441 pp | 0.02% -0.004 pp | USD97.09 +9.3% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 10.13M -110.8K (-1.1%) | 1.08B -225.6M (-17.3%) | 10.08% -0.100 pp | 0.02% -0.004 pp | USD49.68 +113.6% | 32 qtrs — |
| 4 | INVESCO LTD. | 4.97M -154.0K (-3.0%) | 527.81M -123.4M (-18.9%) | 4.95% -0.148 pp | 0.08% -0.022 pp | USD64.37 +64.9% | 32 qtrs — |
| 5 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.81M +948.2K (+24.6%) | 510.05M +20.1M (+4.1%) | 4.78% +0.947 pp | 0.06% +0.003 pp | USD111.38 -4.7% | 32 qtrs — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 3.38M +603.5K (+21.7%) | 359.27M +6.0M (+1.7%) | 3.38% +0.613 pp | 0.06% +0.001 pp | USD63.38 +67.5% | 32 qtrs — |
| 7 | STATE STREET CORP | 3.09M +6.4K (+0.2%) | 327.75M -63.7M (-16.3%) | 3.07% +0.010 pp | 0.01% -0.003 pp | USD52.80 +101.0% | 32 qtrs — |
| 8 | T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.72M +581.8K (+27.2%) | 289.01M +17.0M (+6.3%) | 2.72% +0.589 pp | 0.18% +0.016 pp | USD97.70 +8.6% | 5 qtrs — |
| 9 | FULLER & THALER ASSET MANAGEMENT, INC. | 2.05M -8.3K (-0.4%) | 217.98M -43.9M (-16.8%) | 2.04% -0.006 pp | 0.74% -0.154 pp | USD103.51 +2.5% | 6 qtrs — |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.95M +137.9K (+7.6%) | 206.61M -23.1M (-10.1%) | 1.94% +0.139 pp | 0.01% -0.002 pp | USD61.91 +71.4% | 32 qtrs — |
| 11 | ALLIANCEBERNSTEIN L.P. | 1.87M -649.1K (-25.8%) | 198.14M -121.4M (-38.0%) | 1.86% -0.643 pp | 0.06% -0.038 pp | USD101.07 +5.0% | 32 qtrs — |
| 12 | DIMENSIONAL FUND ADVISORS LP | 1.62M +8.0K (+0.5%) | 172.40M -32.9M (-16.0%) | 1.62% +0.010 pp | 0.04% -0.008 pp | USD55.03 +92.9% | 32 qtrs — |
| 13 | MILLENNIUM MANAGEMENT LLC | 1.44M +211.4K (+17.3%) | 152.31M -3.1M (-2.0%) | 1.43% +0.212 pp | 0.06% -0.002 pp | USD119.83 -11.4% | 31 qtrs — |
| 14 | RAYMOND JAMES FINANCIAL INC | 1.37M -166.7K (-10.8%) | 147.07M -48.7M (-24.9%) | 1.37% -0.160 pp | 0.05% -0.017 pp | USD106.83 -0.6% | 5 qtrs — |
| 15 | NORGES BANK | 1.26M +1.3M (+100.0%) | 133.22M +133.2M (+100.0%) | 1.25% +1.249 pp | 0.01% +0.014 pp | USD106.14 +0.0% | 1 qtrs NEW |
| 16 | THRIVENT FINANCIAL FOR LUTHERANS | 1.18M -18.3K (-1.5%) | 124.66M -26.9M (-17.7%) | 1.17% -0.017 pp | 0.22% -0.077 pp | USD102.39 +3.7% | 32 qtrs — |
| 17 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.16M +96.4K (+9.0%) | 123.53M -12.1M (-8.9%) | 1.16% +0.097 pp | 0.07% -0.013 pp | USD79.85 +32.9% | 21 qtrs — |
| 18 | JPMORGAN CHASE & CO | 1.10M -311.3K (-22.1%) | 116.65M -62.5M (-34.9%) | 1.09% -0.308 pp | 0.01% -0.003 pp | USD52.51 +102.1% | 32 qtrs — |
| 19 | SUMITOMO MITSUI TRUST HOLDINGS, INC. | 1.01M +248.3K (+32.6%) | 107.27M +10.4M (+10.8%) | 1.01% +0.248 pp | 0.06% +0.007 pp | USD69.16 +53.5% | 22 qtrs — |
| 20 | BANK OF AMERICA CORP /DE/ | 961.2K +92.7K (+10.7%) | 102.02M -8.3M (-7.5%) | 0.96% +0.093 pp | 0.01% 0.000 pp | USD97.13 +9.3% | 32 qtrs — |
| 21 | QUBE RESEARCH & TECHNOLOGIES LTD | 951.7K +258.9K (+37.4%) | 101.01M +13.0M (+14.8%) | 0.95% +0.261 pp | 0.10% +0.012 pp | USD97.08 +9.3% | 12 qtrs — |
| 22 | NORTHERN TRUST CORP | 949.5K -35.9K (-3.6%) | 100.78M -24.4M (-19.5%) | 0.95% -0.032 pp | 0.01% -0.003 pp | USD61.08 +73.8% | 32 qtrs — |
| 23 | MORGAN STANLEY | 919.0K +130.8K (+16.6%) | 97.55M -2.6M (-2.6%) | 0.91% +0.131 pp | 0.01% 0.000 pp | USD73.92 +43.6% | 32 qtrs — |
| 24 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 915.9K +112.6K (+14.0%) | 97.22M -4.8M (-4.7%) | 0.91% +0.113 pp | 0.27% +0.007 pp | USD55.42 +91.5% | 32 qtrs — |
| 25 | BROWN ADVISORY INC | 912.8K -100.0K (-9.9%) | 96.88M -31.8M (-24.7%) | 0.91% -0.099 pp | 0.14% -0.032 pp | USD53.88 +97.0% | 24 qtrs — |
| 26 | FRANKLIN RESOURCES INC | 901.0K -173.0K (-16.1%) | 95.64M -40.8M (-29.9%) | 0.90% -0.171 pp | 0.02% -0.011 pp | USD94.82 +11.9% | 21 qtrs — |
| 27 | BANK OF NEW YORK MELLON CORP | 886.3K -124.8K (-12.3%) | 94.08M -34.4M (-26.8%) | 0.88% -0.123 pp | 0.02% -0.008 pp | USD50.07 +112.0% | 32 qtrs — |
| 28 | AMERIPRISE FINANCIAL INC | 854.3K +123.5K (+16.9%) | 90.67M -2.1M (-2.3%) | 0.85% +0.126 pp | 0.02% -0.001 pp | USD77.06 +37.7% | 32 qtrs — |
| 29 | TD ASSET MANAGEMENT INC | 811.2K -112.0K (-12.1%) | 86.10M -31.2M (-26.6%) | 0.81% -0.111 pp | 0.07% -0.026 pp | USD65.15 +62.9% | 32 qtrs — |
| 30 | TWO SIGMA INVESTMENTS, LP | 804.9K +299.3K (+59.2%) | 85.44M +21.2M (+33.0%) | 0.80% +0.298 pp | 0.12% +0.025 pp | USD110.46 -3.9% | 6 qtrs — |
| 31 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 783.1K -105.0K (-11.8%) | 83.12M -29.7M (-26.3%) | 0.78% -0.104 pp | 0.18% -0.080 pp | USD78.85 +34.6% | 32 qtrs — |
| 32 | EPOCH INVESTMENT PARTNERS, INC. | 767.2K -120.5K (-13.6%) | 81.43M -31.3M (-27.8%) | 0.77% -0.117 pp | 0.46% -0.157 pp | USD66.00 +60.8% | 32 qtrs — |
| 33 | COPELAND CAPITAL MANAGEMENT, LLC | 764.7K -41.8K (-5.2%) | 81.17M -21.3M (-20.8%) | 0.76% -0.041 pp | 1.81% -0.323 pp | USD52.28 +103.0% | 33 qtrs — |
| 34 | POINT72 ASSET MANAGEMENT, L.P. | 695.6K +695.1K (+165,511.2%) | 73.83M +73.8M (+138,288.5%) | 0.69% +0.694 pp | 0.08% +0.083 pp | USD106.15 0.0% | 2 qtrs — |
| 35 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 680.4K -15.1K (-2.2%) | 72.22M -16.1M (-18.3%) | 0.68% -0.012 pp | 0.01% -0.003 pp | USD53.78 +97.4% | 32 qtrs — |
| 36 | AMERICAN CENTURY COMPANIES INC | 606.3K -111.8K (-15.6%) | 64.35M -26.9M (-29.5%) | 0.60% -0.111 pp | 0.03% -0.014 pp | USD87.79 +20.9% | 28 qtrs — |
| 37 | CAPITAL RESEARCH GLOBAL INVESTORS | 597.3K -5.2K (-0.9%) | 63.40M -13.1M (-17.2%) | 0.59% -0.005 pp | 0.01% -0.003 pp | USD46.85 +126.6% | 32 qtrs — |
| 38 | AQR CAPITAL MANAGEMENT LLC | 577.3K -68.0K (-10.5%) | 61.27M -20.4M (-25.0%) | 0.58% -0.065 pp | 0.03% -0.020 pp | USD101.10 +5.0% | 32 qtrs — |
| 39 | JENNISON ASSOCIATES LLC | 560.8K -333.7K (-37.3%) | 59.52M -54.1M (-47.6%) | 0.56% -0.331 pp | 0.04% -0.030 pp | USD98.61 +7.6% | 5 qtrs — |
| 40 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 553.2K +397.9K (+256.2%) | 58.71M +39.0M (+197.7%) | 0.55% +0.396 pp | 0.21% +0.140 pp | USD112.00 -5.2% | 2 qtrs — |
| 41 | CONGRESS ASSET MANAGEMENT CO /MA | 548.2K -71.2K (-11.5%) | 58.18M -20.5M (-26.0%) | 0.55% -0.070 pp | 0.41% -0.114 pp | USD122.63 -13.4% | 3 qtrs — |
| 42 | ALLIANZ ASSET MANAGEMENT GMBH | 515.2K +12.4K (+2.5%) | 54.68M -9.2M (-14.4%) | 0.51% +0.013 pp | 0.06% -0.016 pp | USD97.03 +9.4% | 10 qtrs — |
| 43 | POLAR CAPITAL HOLDINGS PLC | 469.5K -16.9K (-3.5%) | 49.83M -12.0M (-19.3%) | 0.47% -0.016 pp | 0.19% -0.105 pp | USD122.83 -13.6% | 7 qtrs — |
| 44 | GOLDMAN SACHS GROUP INC | 451.8K +119.1K (+35.8%) | 47.95M +5.7M (+13.5%) | 0.45% +0.119 pp | 0.01% +0.001 pp | USD97.45 +8.9% | 32 qtrs — |
| 45 | SYSTEMATIC FINANCIAL MANAGEMENT LP | 440.8K +15.5K (+3.6%) | 46.78M -7.2M (-13.4%) | 0.44% +0.016 pp | 1.10% -0.211 pp | USD57.32 +85.2% | 32 qtrs — |
| 46 | BAHL & GAYNOR INC | 437.0K +15.2K (+3.6%) | 46.38M -7.2M (-13.4%) | 0.43% +0.016 pp | 0.23% -0.031 pp | USD109.09 -2.7% | 33 qtrs — |
| 47 | FMR LLC | 434.6K -618.0K (-58.7%) | 46.13M -87.6M (-65.5%) | 0.43% -0.613 pp | 0.00% -0.005 pp | USD68.44 +55.1% | 32 qtrs — |
| 48 | VICTORY CAPITAL MANAGEMENT INC | 426.9K -37.2K (-8.0%) | 45.31M -13.6M (-23.1%) | 0.42% -0.037 pp | 0.03% -0.009 pp | USD52.84 +100.9% | 32 qtrs — |
| 49 | HOLOCENE ADVISORS, LP | 404.1K +404.1K (+100.0%) | 42.89M +42.9M (+100.0%) | 0.40% +0.402 pp | 0.09% +0.090 pp | USD106.14 +0.0% | 23 qtrs — |
| 50 | BALYASNY ASSET MANAGEMENT L.P. | 381.2K +381.2K (+100.0%) | 40.46M +40.5M (+100.0%) | 0.38% +0.380 pp | 0.05% +0.051 pp | USD106.14 +0.0% | 8 qtrs — |
| 51 | SEI INVESTMENTS CO | 377.4K +123.2K (+48.5%) | 40.06M +7.8M (+24.1%) | 0.38% +0.124 pp | 0.04% +0.005 pp | USD77.66 +36.7% | 32 qtrs — |
| 52 | REINHART PARTNERS, INC. | 372.8K +10.2K (+2.8%) | 39.57M -6.5M (-14.1%) | 0.37% +0.011 pp | 1.19% -0.312 pp | USD52.99 +100.3% | 32 qtrs — |
| 53 | UBS GROUP AG | 368.2K +256.2K (+228.8%) | 39.09M +24.9M (+174.7%) | 0.37% +0.255 pp | 0.01% +0.004 pp | USD99.63 +6.5% | 32 qtrs — |
| 54 | TWO SIGMA ADVISERS, LP | 359.1K +139.7K (+63.7%) | 38.11M +10.2M (+36.8%) | 0.36% +0.139 pp | 0.07% +0.018 pp | USD106.31 -0.2% | 32 qtrs — |
| 55 | OBERWEIS ASSET MANAGEMENT INC/ | 359.0K +171.0 (+0.0%) | 38.10M -7.5M (-16.4%) | 0.36% +0.002 pp | 1.39% -0.352 pp | USD80.35 +32.1% | 11 qtrs — |
| 56 | TIMESSQUARE CAPITAL MANAGEMENT, LLC | 346.3K -16.3K (-4.5%) | 36.76M -9.3M (-20.2%) | 0.34% -0.016 pp | 0.55% -0.105 pp | USD60.47 +75.5% | 32 qtrs — |
| 57 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 344.1K +300.5K (+690.2%) | 36.60M +31.2M (+575.0%) | 0.34% +0.299 pp | 0.06% +0.051 pp | USD103.82 +2.2% | 17 qtrs — |
| 58 | SILVERCREST ASSET MANAGEMENT GROUP LLC | 344.7K -16.5K (-4.6%) | 36.59M -9.3M (-20.2%) | 0.34% -0.015 pp | 0.25% -0.052 pp | USD79.52 +33.5% | 32 qtrs — |
| 59 | D. E. SHAW & CO., INC. | 338.3K +275.6K (+439.5%) | 35.91M +27.9M (+350.8%) | 0.34% +0.275 pp | 0.02% +0.015 pp | USD107.27 -1.1% | 12 qtrs — |
| 60 | ABRDN PLC | 337.8K -14.0K (-4.0%) | 35.86M -8.4M (-19.0%) | 0.34% -0.014 pp | 0.06% -0.015 pp | USD96.52 +10.0% | 5 qtrs — |
| 61 | LEEWARD INVESTMENTS, LLC - MA | 334.0K -7.8K (-2.3%) | 35.45M -8.0M (-18.3%) | 0.33% -0.007 pp | 1.79% -0.424 pp | USD49.98 +112.4% | 16 qtrs — |
| 62 | ACADIAN ASSET MANAGEMENT LLC | 332.5K +166.4K (+100.1%) | 35.28M +14.2M (+67.3%) | 0.33% +0.166 pp | 0.06% +0.021 pp | USD112.89 -6.0% | 7 qtrs — |
| 63 | TUDOR INVESTMENT CORP ET AL | 324.8K +114.1K (+54.1%) | 34.47M +7.7M (+28.8%) | 0.32% +0.115 pp | 0.06% +0.018 pp | USD117.94 -10.0% | 12 qtrs — |
| 64 | ENVESTNET ASSET MANAGEMENT INC | 306.9K -43.9K (-12.5%) | 32.58M -12.0M (-26.9%) | 0.31% -0.043 pp | 0.01% -0.003 pp | USD80.98 +31.1% | 32 qtrs — |
| 65 | UBS ASSET MANAGEMENT AMERICAS INC | 293.7K -37.8K (-11.4%) | 31.17M -10.9M (-26.0%) | 0.29% -0.037 pp | 0.01% -0.003 pp | USD83.65 +26.9% | 32 qtrs — |
| 66 | NEUBERGER BERMAN GROUP LLC | 283.9K +86.5K (+43.8%) | 30.14M +5.1M (+20.4%) | 0.28% +0.087 pp | 0.02% +0.004 pp | USD100.00 +6.1% | 32 qtrs — |
| 67 | HSBC HOLDINGS PLC | 276.2K +222.3K (+412.7%) | 29.61M +22.8M (+333.4%) | 0.27% +0.221 pp | 0.02% +0.011 pp | USD108.12 -1.8% | 13 qtrs — |
| 68 | FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 267.7K +59.2K (+28.4%) | 28.41M +1.9M (+7.3%) | 0.27% +0.059 pp | 0.15% +0.008 pp | USD76.57 +38.6% | 32 qtrs — |
| 69 | SQUAREPOINT OPS LLC | 265.2K +250.9K (+1,752.2%) | 28.15M +26.3M (+1,447.8%) | 0.26% +0.251 pp | 0.03% +0.028 pp | USD105.55 +0.6% | 13 qtrs — |
| 70 | CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 263.9K -51.6K (-16.4%) | 28.01M -12.1M (-30.1%) | 0.26% -0.051 pp | 0.02% -0.008 pp | USD60.98 +74.1% | 32 qtrs — |
| 71 | NUVEEN, LLC | 260.5K -9.8K (-3.6%) | 27.65M -6.7M (-19.5%) | 0.26% -0.009 pp | 0.01% -0.002 pp | USD102.78 +3.3% | 4 qtrs — |
| 72 | RHUMBLINE ADVISERS | 257.5K -8.5K (-3.2%) | 27.33M -6.5M (-19.1%) | 0.26% -0.008 pp | 0.02% -0.005 pp | USD49.14 +116.0% | 32 qtrs — |
| 73 | BARCLAYS PLC | 248.9K +188.0K (+308.8%) | 26.42M +20.5M (+349.0%) | 0.25% +0.187 pp | 0.01% +0.005 pp | USD100.99 +5.1% | 32 qtrs — |
| 74 | FARALLON CAPITAL MANAGEMENT LLC | 234.5K -336.5K (-58.9%) | 24.89M -47.6M (-65.7%) | 0.23% -0.334 pp | 0.12% -0.180 pp | USD98.04 +8.3% | 11 qtrs — |
| 75 | JANE STREET GROUP, LLC | 227.2K +80.2K (+54.5%) | 24.11M +5.4M (+29.1%) | 0.23% +0.080 pp | 0.00% +0.001 pp | USD113.34 -6.4% | 31 qtrs — |
| 76 | BRAUN STACEY ASSOCIATES INC | 222.5K -1.2K (-0.5%) | 23.62M -4.8M (-16.9%) | 0.22% -0.001 pp | 0.77% -0.165 pp | USD107.05 -0.9% | 5 qtrs — |
| 77 | TRILLIUM ASSET MANAGEMENT, LLC | 217.7K +11.8K (+5.7%) | 23.42M -2.7M (-10.5%) | 0.22% +0.012 pp | 0.72% +0.026 pp | USD99.03 +7.2% | 8 qtrs — |
| 78 | RETIREMENT SYSTEMS OF ALABAMA | 220.7K -1.0K (-0.5%) | 23.42M -4.7M (-16.8%) | 0.22% -0.001 pp | 0.08% -0.018 pp | USD47.85 +121.8% | 32 qtrs — |
| 79 | SCHRODER INVESTMENT MANAGEMENT GROUP | 215.5K -162.4K (-43.0%) | 23.20M -24.4M (-51.2%) | 0.21% -0.161 pp | 0.02% -0.019 pp | USD61.81 +71.7% | 32 qtrs — |
| 80 | PRINCIPAL FINANCIAL GROUP INC | 216.3K -55.5K (-20.4%) | 22.96M -11.6M (-33.5%) | 0.22% -0.055 pp | 0.01% -0.006 pp | USD66.93 +58.6% | 32 qtrs — |
| 81 | TREASURER OF THE STATE OF NORTH CAROLINA | 213.6K -3.4K (-1.6%) | 22.67M -4.9M (-17.7%) | 0.21% -0.003 pp | 0.07% -0.012 pp | USD96.41 +10.1% | 31 qtrs — |
| 82 | BLAIR WILLIAM & CO/IL | 213.5K -2.6K (-1.2%) | 22.67M -4.8M (-17.4%) | 0.21% -0.002 pp | 0.06% -0.012 pp | USD55.64 +90.8% | 32 qtrs — |
| 83 | VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | 206.1K -214.0K (-50.9%) | 21.87M -31.5M (-59.0%) | 0.21% -0.212 pp | 0.19% -0.289 pp | USD74.01 +43.4% | 21 qtrs — |
| 84 | SWISS NATIONAL BANK | 198.6K +3.2K (+1.6%) | 21.08M -3.7M (-15.1%) | 0.20% +0.003 pp | 0.01% -0.002 pp | USD50.36 +110.8% | 32 qtrs — |
| 85 | CAPITOLIS LIQUID GLOBAL MARKETS LLC | 185.0K +185.0K (+100.0%) | 19.64M +19.6M (+100.0%) | 0.18% +0.184 pp | 0.12% +0.117 pp | USD106.14 +0.0% | 1 qtrs NEW |
| 86 | FIRST TRUST ADVISORS LP | 170.8K -35.5K (-17.2%) | 18.12M -8.1M (-30.8%) | 0.17% -0.035 pp | 0.01% -0.006 pp | USD68.57 +54.8% | 31 qtrs — |
| 87 | TREXQUANT INVESTMENT LP | 161.6K +102.2K (+171.7%) | 17.16M +9.6M (+127.1%) | 0.16% +0.102 pp | 0.15% +0.075 pp | USD111.09 -4.5% | 12 qtrs — |
| 88 | WELLS FARGO & COMPANY/MN | 161.2K +6.6K (+4.3%) | 17.11M -2.5M (-12.9%) | 0.16% +0.007 pp | 0.00% -0.001 pp | USD65.47 +62.1% | 32 qtrs — |
| 89 | LEGAL & GENERAL GROUP PLC | 157.6K -30.2K (-16.1%) | 16.73M -7.1M (-29.9%) | 0.16% -0.030 pp | 0.00% -0.002 pp | USD59.92 +77.1% | 32 qtrs — |
| 90 | DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 156.9K -63.3K (-28.7%) | 16.66M -11.3M (-40.4%) | 0.16% -0.062 pp | 0.01% -0.010 pp | USD100.58 +5.5% | 5 qtrs — |
| 91 | ALPS ADVISORS INC | 154.4K -9.0K (-5.5%) | 16.39M -4.4M (-21.0%) | 0.15% -0.009 pp | 0.10% -0.020 pp | USD70.64 +50.3% | 15 qtrs — |
| 92 | SEGALL BRYANT & HAMILL, LLC | 148.3K +20.4K (+15.9%) | 15.74M -510.3K (-3.1%) | 0.15% +0.020 pp | 0.21% -0.004 pp | USD75.11 +41.3% | 29 qtrs — |
| 93 | RHENMAN & PARTNERS ASSET MANAGEMENT AB | 146.3K +26.9K (+22.5%) | 15.52M +358.2K (+2.4%) | 0.15% +0.027 pp | 1.45% -0.227 pp | USD111.07 -4.4% | 8 qtrs — |
| 94 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 143.6K -12.0K (-7.7%) | 15.35M -4.4M (-22.3%) | 0.14% -0.011 pp | 0.01% -0.004 pp | USD84.03 +26.3% | 32 qtrs — |
| 95 | LOS ANGELES CAPITAL MANAGEMENT LLC | 128.5K +33.9K (+35.8%) | 15.00M +3.0M (+24.9%) | 0.13% +0.034 pp | 0.05% +0.010 pp | USD112.11 -5.3% | 7 qtrs — |
| 96 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 136.1K -23.7K (-14.8%) | 14.45M -5.9M (-28.8%) | 0.14% -0.023 pp | 0.00% -0.002 pp | USD106.34 -0.2% | 20 qtrs — |
| 97 | INTECH INVESTMENT MANAGEMENT LLC | 132.2K +110.4K (+505.6%) | 14.03M +11.3M (+406.1%) | 0.13% +0.110 pp | 0.13% +0.101 pp | USD104.24 +1.8% | 9 qtrs — |
| 98 | ASSET MANAGEMENT ONE CO., LTD. | 129.2K +72.7K (+128.7%) | 13.79M +6.6M (+92.2%) | 0.13% +0.072 pp | 0.04% +0.018 pp | USD110.84 -4.2% | 9 qtrs — |
| 99 | APTUS CAPITAL ADVISORS, LLC | 126.7K +526.0 (+0.4%) | 13.45M -2.6M (-16.1%) | 0.13% +0.001 pp | 0.10% -0.020 pp | USD84.14 +26.1% | 14 qtrs — |
| 100 | LIGHTROCK NETHERLANDS B.V. | 430.0K +336.7K (+360.8%) | 3.85M -6.2M (-61.8%) | 0.43% +0.335 pp | 0.80% -1.839 pp | USD104.40 +1.7% | 5 qtrs — |
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | TimesSquare Quality Mid Cap Growth ETF TSCM | 2.37% | 525.2K | 0.55% |
| 2 | Inspire Growth ETF GLRY | 2.26% | 3.83M | 0.87% |
| 3 | Opus Small Cap Value ETF OSCV | 2.16% | 14.79M | 0.79% |
| 4 | First Trust Health Care AlphaDEX Fund FXH | 1.89% | 18.83M | 0.61% |
| 5 | ALPS O'Shares U.S. Small-Cap Quality Dividend ETF OUSM | 1.86% | 16.25M | 0.48% |
| 6 | State Street SPDR S&P Health Care Services ETF XHS | 1.71% | 3.49M | 0.35% |
| 7 | iShares U.S. Healthcare Providers ETF IHF | 1.59% | 19.02M | 0.38% |
| 8 | First Trust Small Cap BuyWrite Income ETF FTKI | 1.54% | 387.5K | 0.86% |
| 9 | Invesco S&P MidCap 400 GARP ETF GRPM | 1.34% | 6.40M | 0.35% |
| 10 | KraneShares Man Buyout Beta Index ETF BUYO | 1.25% | 206.5K | 0.89% |
Insider Activity
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-16 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 334 | 106.48 | 35.6K | 15,803 | D | ↗ |
| 2026-04-16 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 261 | 106.17 | 27.7K | 7,452 | D | ↗ |
| 2026-04-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 27 | 0.00 | — | 15,196 | D | ↗ |
| 2026-04-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 39 | 0.00 | — | 21,298 | D | ↗ |
| 2026-04-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 19 | 0.00 | — | 15,469 | D | ↗ |
| 2026-04-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 17 | 0.00 | — | 9,929 | D | ↗ |
| 2026-04-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 85 | 0.00 | — | 47,924 | D | ↗ |
| 2026-04-15 | Hayes Cain A | Director | A-Award | A | Encompass Health Common Stock | 1 | 0.00 | — | 458 | D | ↗ |
| 2026-04-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 85 | 0.00 | — | 47,924 | D | ↗ |
| 2026-04-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 9 | 0.00 | — | 7,191 | D | ↗ |
| 2026-04-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 27 | 0.00 | — | 18,686 | D | ↗ |
| 2026-03-09 | Fay Edmund | Officer | S-Sale | D | Encompass Health Common Stock | 11,937 | 107.00 | 1.28M | 89,325 | D | ↗ |
| 2026-03-02 | Tuer Patrick William | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 10,502 | 108.06 | 1.13M | 10,502 | D | ↗ |
| 2026-03-02 | Tarr Mark J | Director / Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 35,461 | 108.06 | 3.83M | 35,461 | D | ↗ |
| 2026-03-02 | Darby John Patrick | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 5,967 | 108.06 | 644.8K | 5,967 | D | ↗ |
| 2026-03-02 | COLTHARP DOUGLAS E | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 12,275 | 108.06 | 1.33M | 12,275 | D | ↗ |
| 2026-02-28 | Tuer Patrick William | Officer | F-InKind | D | Encompass Health Common Stock | 545 | 107.88 | 58.8K | 25,437 | D | ↗ |
| 2026-02-28 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 2,187 | 107.88 | 235.9K | 440,962 | D | ↗ |
| 2026-02-28 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 307 | 107.88 | 33.1K | 74,694 | D | ↗ |
| 2026-02-28 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 280 | 107.88 | 30.2K | 101,262 | D | ↗ |
| 2026-02-28 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 416 | 107.88 | 44.9K | 83,947 | D | ↗ |
| 2026-02-28 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 369 | 107.88 | 39.8K | 17,644 | D | ↗ |
| 2026-02-28 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 776 | 107.88 | 83.7K | 69,377 | D | ↗ |
| 2026-02-23 | Tuer Patrick William | Officer | F-InKind | D | Encompass Health Common Stock | 506 | 106.15 | 53.7K | 25,982 | D | ↗ |
| 2026-02-23 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 2,488 | 106.15 | 264.1K | 443,149 | D | ↗ |
| 2026-02-23 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 404 | 106.15 | 42.9K | 75,001 | D | ↗ |
| 2026-02-23 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 380 | 106.15 | 40.3K | 101,542 | D | ↗ |
| 2026-02-23 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 6,990 | 106.15 | 742.0K | 84,363 | D | ↗ |
| 2026-02-23 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 440 | 106.15 | 46.7K | 18,013 | D | ↗ |
| 2026-02-23 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 14,818 | 106.15 | 1.57M | 70,153 | D | ↗ |
| 2026-02-20 | Tuer Patrick William | Officer | F-InKind | D | Encompass Health Common Stock | 405 | 106.55 | 43.2K | 26,488 | D | ↗ |
| 2026-02-20 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 1,797 | 106.55 | 191.5K | 445,637 | D | ↗ |
| 2026-02-20 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 228 | 106.55 | 24.3K | 75,405 | D | ↗ |
| 2026-02-20 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 208 | 106.55 | 22.2K | 101,922 | D | ↗ |
| 2026-02-20 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 328 | 106.55 | 34.9K | 91,353 | D | ↗ |
| 2026-02-20 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 287 | 106.55 | 30.6K | 18,453 | D | ↗ |
| 2026-02-20 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 674 | 106.55 | 71.8K | 84,971 | D | ↗ |
| 2026-02-19 | Tuer Patrick William | Officer | A-Award | A | Encompass Health Common Stock | 3,790 | 0.00 | — | 30,086 | D | ↗ |
| 2026-02-19 | Tarr Mark J | Director / Officer | A-Award | A | Encompass Health Common Stock | 12,796 | 0.00 | — | 490,812 | D | ↗ |
| 2026-02-19 | Price Andrew L | Officer | A-Award | A | Encompass Health Common Stock | 1,560 | 0.00 | — | 79,325 | D | ↗ |
| 2026-02-19 | Fay Edmund | Officer | A-Award | A | Encompass Health Common Stock | 1,430 | 0.00 | — | 105,609 | D | ↗ |
| 2026-02-19 | Darby John Patrick | Officer | A-Award | A | Encompass Health Common Stock | 2,154 | 0.00 | — | 99,584 | D | ↗ |
| 2026-02-19 | Charbonneau Elissa Joy | Officer | A-Award | A | Encompass Health Common Stock | 1,884 | 0.00 | — | 22,756 | D | ↗ |
| 2026-02-19 | COLTHARP DOUGLAS E | Officer | A-Award | A | Encompass Health Common Stock | 4,430 | 0.00 | — | 102,353 | D | ↗ |
| 2026-02-18 | Tuer Patrick William | Officer | A-Award | A | Encompass Health Common Stock | 10,254 | 0.00 | — | 26,296 | D | ↗ |
| 2026-02-18 | Tarr Mark J | Director / Officer | A-Award | A | Encompass Health Common Stock | 100,946 | 0.00 | — | 478,016 | D | ↗ |
| 2026-02-18 | Price Andrew L | Officer | A-Award | A | Encompass Health Common Stock | 8,178 | 0.00 | — | 77,765 | D | ↗ |
| 2026-02-18 | Fay Edmund | Officer | A-Award | A | Encompass Health Common Stock | 7,690 | 0.00 | — | 104,179 | D | ↗ |
| 2026-02-18 | Darby John Patrick | Officer | A-Award | A | Encompass Health Common Stock | 17,720 | 0.00 | — | 97,430 | D | ↗ |
| 2026-02-18 | Charbonneau Elissa Joy | Officer | A-Award | A | Encompass Health Common Stock | 8,914 | 0.00 | — | 20,872 | D | ↗ |
| 2026-02-18 | COLTHARP DOUGLAS E | Officer | A-Award | A | Encompass Health Common Stock | 37,588 | 0.00 | — | 97,923 | D | ↗ |
| 2026-02-11 | Tarr Mark J | Director / Officer | S-Sale | D | Encompass Health Common Stock | 16,216 | 108.03 | 1.75M | 510,854 | D | ↗ |
| 2026-02-10 | Tuer Patrick William | Officer | S-Sale | D | Encompass Health Common Stock | 2,804 | 107.62 | 301.8K | 16,042 | D | ↗ |
| 2026-01-30 | Hayes Cain A | Director | A-Award | A | Encompass Health Common Stock | 457 | 0.00 | — | 457 | D | ↗ |
| 2026-01-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 28 | 0.00 | — | 15,169 | D | ↗ |
| 2026-01-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 40 | 0.00 | — | 21,259 | D | ↗ |
| 2026-01-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 346 | 103.07 | 35.7K | 15,450 | D | ↗ |
| 2026-01-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 17 | 0.00 | — | 9,912 | D | ↗ |
| 2026-01-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 87 | 0.00 | — | 47,839 | D | ↗ |
| 2026-01-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 87 | 0.00 | — | 47,839 | D | ↗ |
| 2026-01-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 269 | 102.82 | 27.7K | 7,182 | D | ↗ |
| 2026-01-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 28 | 0.00 | — | 18,659 | D | ↗ |
| 2025-10-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 23 | 0.00 | — | 15,141 | D | ↗ |
| 2025-10-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 33 | 0.00 | — | 21,219 | D | ↗ |
| 2025-10-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 16 | 0.00 | — | 14,797 | D | ↗ |
| 2025-10-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 14 | 0.00 | — | 9,895 | D | ↗ |
| 2025-10-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 73 | 0.00 | — | 47,752 | D | ↗ |
| 2025-10-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 73 | 0.00 | — | 47,752 | D | ↗ |
| 2025-10-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 223 | 123.21 | 27.5K | 6,904 | D | ↗ |
| 2025-10-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 23 | 0.00 | — | 18,631 | D | ↗ |
| 2025-08-27 | Tuer Patrick William | Officer | S-Sale | D | Encompass Health Common Stock | 1,020 | 123.59 | 126.1K | 18,846 | D | ↗ |
| 2025-08-21 | COLTHARP DOUGLAS E | Officer | G-Gift | D | Encompass Health Common Stock | 27,480 | 0.00 | — | 37,749 | I | ↗ |
| 2025-07-16 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 333 | 106.89 | 35.6K | 14,781 | D | ↗ |
| 2025-07-16 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 260 | 106.48 | 27.7K | 6,674 | D | ↗ |
| 2025-07-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 15,118 | D | ↗ |
| 2025-07-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 34 | 0.00 | — | 21,186 | D | ↗ |
| 2025-07-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 17 | 0.00 | — | 14,448 | D | ↗ |
| 2025-07-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 15 | 0.00 | — | 9,881 | D | ↗ |
| 2025-07-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 14,764 | D | ↗ |
| 2025-07-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 74 | 0.00 | — | 47,679 | D | ↗ |
| 2025-07-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 74 | 0.00 | — | 47,679 | D | ↗ |
| 2025-07-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 8 | 0.00 | — | 6,414 | D | ↗ |
| 2025-07-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 18,608 | D | ↗ |
| 2025-05-20 | Tarr Mark J | Director / Officer | M-Exempt | A | Encompass Health Common Stock | 62,078 | 44.67 | 2.77M | 645,454 | D | ↗ |
| 2025-05-14 | Fay Edmund | Officer | G-Gift | D | Encompass Health Common Stock | 3,667 | 0.00 | — | 96,489 | D | ↗ |
| 2025-05-06 | Charbonneau Elissa Joy | Officer | S-Sale | D | Encompass Health Common Stock | 4,279 | 116.61 | 499.0K | 11,958 | D | ↗ |
| 2025-05-01 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 15,094 | D | ↗ |
| 2025-05-01 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 21,152 | D | ↗ |
| 2025-05-01 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 14,431 | D | ↗ |
| 2025-05-01 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 9,866 | D | ↗ |
| 2025-05-01 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 14,740 | D | ↗ |
| 2025-05-01 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 47,605 | D | ↗ |
| 2025-05-01 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 47,605 | D | ↗ |
| 2025-05-01 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 6,406 | D | ↗ |
| 2025-05-01 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 1,424 | 0.00 | — | 18,584 | D | ↗ |
| 2025-04-30 | Tuer Patrick William | Officer | A-Award | A | Encompass Health Common Stock | 5,984 | 0.00 | — | 19,866 | D | ↗ |
| 2025-04-29 | Darby John Patrick | Officer | M-Exempt | D | Non-qualified Stock Option (Right to Buy) | 10,000 | 35.06 | 350.6K | 4,858 | D | ↗ |
| 2025-04-29 | COLTHARP DOUGLAS E | Officer | S-Sale | D | Encompass Health Common Stock | 26,239 | 114.78 | 3.01M | 77,671 | D | ↗ |
| 2025-04-24 | Tuer Patrick William | Officer | — | — | Encompass Health Common Stock | 0 | 0.00 | — | 13,882 | D | ↗ |
| 2025-04-24 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 268 | 102.56 | 27.5K | 4,982 | D | ↗ |
| 2025-04-22 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 360 | 98.23 | 35.4K | 13,007 | D | ↗ |
| 2025-04-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 23 | 0.00 | — | 13,670 | D | ↗ |
| 2025-04-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 33 | 0.00 | — | 19,728 | D | ↗ |
| 2025-04-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 15 | 0.00 | — | 12,647 | D | ↗ |
| 2025-04-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 13 | 0.00 | — | 8,442 | D | ↗ |
| 2025-04-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 23 | 0.00 | — | 13,316 | D | ↗ |
| 2025-04-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 76 | 0.00 | — | 46,181 | D | ↗ |
| 2025-04-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 76 | 0.00 | — | 46,181 | D | ↗ |
| 2025-04-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 5 | 0.00 | — | 4,714 | D | ↗ |
| 2025-04-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 23 | 0.00 | — | 17,160 | D | ↗ |
| 2025-03-04 | Tarr Mark J | Director / Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 33,086 | 98.45 | 3.26M | 33,086 | D | ↗ |
| 2025-03-04 | Darby John Patrick | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 6,032 | 98.45 | 593.9K | 6,032 | D | ↗ |
| 2025-03-04 | COLTHARP DOUGLAS E | Officer | A-Award | A | Non-qualified Stock Option (Right to Buy) | 12,407 | 98.45 | 1.22M | 12,407 | D | ↗ |
| 2025-02-28 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 2,187 | 100.14 | 219.0K | 527,070 | D | ↗ |
| 2025-02-28 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 304 | 100.14 | 30.4K | 69,587 | D | ↗ |
| 2025-02-28 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 276 | 100.14 | 27.6K | 100,156 | D | ↗ |
| 2025-02-28 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 416 | 100.14 | 41.7K | 79,710 | D | ↗ |
| 2025-02-28 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 364 | 100.14 | 36.5K | 16,237 | D | ↗ |
| 2025-02-28 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 776 | 100.14 | 77.7K | 60,335 | D | ↗ |
| 2025-02-25 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 2,896 | 100.63 | 291.4K | 529,257 | D | ↗ |
| 2025-02-25 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 410 | 100.63 | 41.3K | 69,891 | D | ↗ |
| 2025-02-25 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 384 | 100.63 | 38.6K | 100,432 | D | ↗ |
| 2025-02-25 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 509 | 100.63 | 51.2K | 80,126 | D | ↗ |
| 2025-02-25 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 506 | 100.63 | 50.9K | 16,601 | D | ↗ |
| 2025-02-25 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 1,079 | 100.63 | 108.6K | 61,111 | D | ↗ |
| 2025-02-24 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 2,488 | 97.53 | 242.7K | 532,153 | D | ↗ |
| 2025-02-24 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 401 | 97.53 | 39.1K | 70,301 | D | ↗ |
| 2025-02-24 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 374 | 97.53 | 36.5K | 100,816 | D | ↗ |
| 2025-02-24 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 437 | 97.53 | 42.6K | 80,635 | D | ↗ |
| 2025-02-24 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 435 | 97.53 | 42.4K | 17,107 | D | ↗ |
| 2025-02-24 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 927 | 97.53 | 90.4K | 62,190 | D | ↗ |
| 2025-02-20 | Tarr Mark J | Director / Officer | A-Award | A | Encompass Health Common Stock | 12,152 | 0.00 | — | 534,641 | D | ↗ |
| 2025-02-20 | Price Andrew L | Officer | A-Award | A | Encompass Health Common Stock | 1,538 | 0.00 | — | 70,702 | D | ↗ |
| 2025-02-20 | Fay Edmund | Officer | A-Award | A | Encompass Health Common Stock | 1,404 | 0.00 | — | 101,190 | D | ↗ |
| 2025-02-20 | Darby John Patrick | Officer | A-Award | A | Encompass Health Common Stock | 2,216 | 0.00 | — | 81,072 | D | ↗ |
| 2025-02-20 | Charbonneau Elissa Joy | Officer | A-Award | A | Encompass Health Common Stock | 1,939 | 0.00 | — | 17,542 | D | ↗ |
| 2025-02-20 | COLTHARP DOUGLAS E | Officer | A-Award | A | Encompass Health Common Stock | 4,557 | 0.00 | — | 63,117 | D | ↗ |
| 2025-02-13 | Price Andrew L | Officer | S-Sale | D | Encompass Health Common Stock | 5,042 | 98.29 | 495.6K | 69,164 | D | ↗ |
| 2025-01-16 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 375 | 94.38 | 35.4K | 12,632 | D | ↗ |
| 2025-01-16 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 292 | 94.40 | 27.6K | 4,709 | D | ↗ |
| 2025-01-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 25 | 0.00 | — | 13,647 | D | ↗ |
| 2025-01-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 36 | 0.00 | — | 19,695 | D | ↗ |
| 2025-01-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 16 | 0.00 | — | 12,257 | D | ↗ |
| 2025-01-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 14 | 0.00 | — | 8,429 | D | ↗ |
| 2025-01-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 25 | 0.00 | — | 13,293 | D | ↗ |
| 2025-01-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 83 | 0.00 | — | 46,105 | D | ↗ |
| 2025-01-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 83 | 0.00 | — | 46,105 | D | ↗ |
| 2025-01-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 6 | 0.00 | — | 4,417 | D | ↗ |
| 2025-01-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 25 | 0.00 | — | 17,137 | D | ↗ |
| 2025-01-01 | Tarr Mark J | Director / Officer | F-InKind | D | Encompass Health Common Stock | 31,609 | 92.35 | 2.92M | 522,489 | D | ↗ |
| 2025-01-01 | Price Andrew L | Officer | F-InKind | D | Encompass Health Common Stock | 2,446 | 92.35 | 225.9K | 74,206 | D | ↗ |
| 2025-01-01 | Fay Edmund | Officer | F-InKind | D | Encompass Health Common Stock | 2,291 | 92.35 | 211.6K | 99,786 | D | ↗ |
| 2025-01-01 | Darby John Patrick | Officer | F-InKind | D | Encompass Health Common Stock | 5,917 | 92.35 | 546.4K | 78,856 | D | ↗ |
| 2025-01-01 | Charbonneau Elissa Joy | Officer | F-InKind | D | Encompass Health Common Stock | 2,991 | 92.35 | 276.2K | 15,603 | D | ↗ |
| 2025-01-01 | COLTHARP DOUGLAS E | Officer | F-InKind | D | Encompass Health Common Stock | 12,438 | 92.35 | 1.15M | 58,560 | D | ↗ |
| 2024-11-13 | COLTHARP DOUGLAS E | Officer | G-Gift | D | Encompass Health Common Stock | 65,229 | 0.00 | — | 70,998 | D | ↗ |
| 2024-10-17 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 362 | 97.53 | 35.3K | 12,241 | D | ↗ |
| 2024-10-17 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 283 | 97.63 | 27.6K | 4,411 | D | ↗ |
| 2024-10-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 13,622 | D | ↗ |
| 2024-10-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 35 | 0.00 | — | 19,659 | D | ↗ |
| 2024-10-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 16 | 0.00 | — | 11,879 | D | ↗ |
| 2024-10-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 14 | 0.00 | — | 8,415 | D | ↗ |
| 2024-10-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 13,268 | D | ↗ |
| 2024-10-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 81 | 0.00 | — | 46,022 | D | ↗ |
| 2024-10-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 81 | 0.00 | — | 46,022 | D | ↗ |
| 2024-10-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 6 | 0.00 | — | 4,128 | D | ↗ |
| 2024-10-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 17,112 | D | ↗ |
| 2024-08-13 | COLTHARP DOUGLAS E | Officer | M-Exempt | A | Encompass Health Common Stock | 12,260 | 35.83 | 439.3K | 148,487 | — | ↗ |
| 2024-07-16 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 426 | 86.63 | 36.9K | 11,863 | — | ↗ |
| 2024-07-16 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 334 | 86.80 | 29.0K | 4,122 | — | ↗ |
| 2024-07-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 13,598 | — | ↗ |
| 2024-07-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 35 | 0.00 | — | 19,624 | — | ↗ |
| 2024-07-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 16 | 0.00 | — | 11,437 | — | ↗ |
| 2024-07-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 13 | 0.00 | — | 8,401 | — | ↗ |
| 2024-07-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 13,244 | — | ↗ |
| 2024-07-15 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 80 | 0.00 | — | 45,941 | — | ↗ |
| 2024-07-15 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 80 | 0.00 | — | 45,941 | — | ↗ |
| 2024-07-15 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 6 | 0.00 | — | 3,788 | — | ↗ |
| 2024-07-15 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 24 | 0.00 | — | 17,074 | — | ↗ |
| 2024-05-24 | Charbonneau Elissa Joy | Officer | S-Sale | D | Encompass Health Common Stock | 10,000 | 85.02 | 850.2K | 18,594 | — | ↗ |
| 2024-05-06 | Darby John Patrick | Officer | M-Exempt | A | Encompass Health Common Stock | 14,543 | 29.06 | 422.6K | 99,316 | — | ↗ |
| 2024-05-03 | CARMICHAEL GREG D | Director | P-Purchase | A | Encompass Health Common Stock | 2,000 | 83.73 | 167.5K | 17,050 | — | ↗ |
| 2024-05-02 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 13,574 | — | ↗ |
| 2024-05-02 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 19,589 | — | ↗ |
| 2024-05-02 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 11,421 | — | ↗ |
| 2024-05-02 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 8,388 | — | ↗ |
| 2024-05-02 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 13,220 | — | ↗ |
| 2024-05-02 | KATZ LESLYE G | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 45,861 | — | ↗ |
| 2024-05-02 | HERMAN JOAN E | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 45,861 | — | ↗ |
| 2024-05-02 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 3,782 | — | ↗ |
| 2024-05-02 | CARMICHAEL GREG D | Director | A-Award | A | Encompass Health Common Stock | 1,978 | 0.00 | — | 15,050 | — | ↗ |
| 2024-04-30 | Tarr Mark J | Director / Officer | M-Exempt | A | Encompass Health Common Stock | 19,460 | 35.83 | 697.3K | 573,558 | — | ↗ |
| 2024-04-16 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 411 | 79.56 | 32.7K | 9,443 | — | ↗ |
| 2024-04-16 | Christie Edward M III | Director | A-Award | A | Encompass Health Common Stock | 314 | 79.65 | 25.0K | 1,804 | — | ↗ |
| 2024-04-16 | CHIDSEY JOHN | Director | A-Award | A | Encompass Health Common Stock | 234 | 79.52 | 18.6K | 162,826 | — | ↗ |
| 2024-04-15 | Williams Terrance | Director | A-Award | A | Encompass Health Common Stock | 21 | 0.00 | — | 11,596 | — | ↗ |
| 2024-04-15 | SCHLICHTING NANCY M | Director | A-Award | A | Encompass Health Common Stock | 33 | 0.00 | — | 17,611 | — | ↗ |
| 2024-04-15 | Reidy Christopher R | Director | A-Award | A | Encompass Health Common Stock | 13 | 0.00 | — | 9,032 | — | ↗ |
| 2024-04-15 | O'Connor Kevin J. | Director | A-Award | A | Encompass Health Common Stock | 11 | 0.00 | — | 6,410 | — | ↗ |
| 2024-04-15 | Maryland Patricia Anne | Director | A-Award | A | Encompass Health Common Stock | 21 | 0.00 | — | 11,242 | — | ↗ |
Executive team
Executive compensation
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Mark J. Tarr President and Chief Executive Officer | 1.10M | — | 5.29M | 1.17M | 2.58M | 165.0K | 10.30M | 62.65% | ↗ |
| 2 | 2025 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 750.0K | — | 1.98M | 437.0K | 1.30M | 48.3K | 4.52M | 53.51% | ↗ |
| 3 | 2025 | Patrick W. Tuer Executive Vice President and Chief Operating Officer | 550.0K | — | 1.43M | — | 786.9K | 81.4K | 2.84M | 50.12% | ↗ |
| 4 | 2025 | Patrick Darby Executive Vice President, General Counsel and Secretary | 625.0K | — | 963.7K | 212.5K | 869.2K | 11.8K | 2.68M | 43.85% | ↗ |
| 5 | 2025 | Elissa J. Charbonneau Chief Medical Officer | 435.0K | — | 518.5K | — | 453.7K | 37.4K | 1.44M | 35.89% | ↗ |
| 6 | 2024 | Mark J. Tarr President and Chief Executive Officer | 1.05M | — | 4.86M | 1.09M | 2.13M | 178.6K | 9.30M | 63.88% | ↗ |
| 7 | 2024 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.72M | 385.1K | 1.01M | 53.8K | 3.87M | 54.50% | ↗ |
| 8 | 2024 | Patrick Darby Executive Vice President, General Counsel and Secretary | 625.0K | — | 923.4K | 206.3K | 792.8K | 11.5K | 2.56M | 44.15% | ↗ |
| 9 | 2024 | Elissa J. Charbonneau Chief Medical Officer | 415.0K | — | 501.8K | — | 350.9K | 23.9K | 1.29M | 38.85% | ↗ |
| 10 | 2024 | Andrew L. Price Chief Accounting Officer | 345.0K | — | 417.2K | — | 291.7K | 19.6K | 1.07M | 38.86% | ↗ |
| 11 | 2023 | Mark J. Tarr President and Chief Executive Officer | 1.05M | — | 4.45M | 952.0K | 2.31M | 66.9K | 8.84M | 61.18% | ↗ |
| 12 | 2023 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 3.57M | 354.5K | 1.09M | 38.1K | 5.75M | 68.16% | ↗ |
| 13 | 2023 | Patrick Darby Executive Vice President, General Counsel and Secretary | 550.0K | — | 1.68M | 167.1K | 757.4K | 11.3K | 3.17M | 58.36% | ↗ |
| 14 | 2023 | Elissa J. Charbonneau Chief Medical Officer | 415.0K | — | 483.8K | — | 381.0K | 18.4K | 1.30M | 37.27% | ↗ |
| 15 | 2023 | Andrew L. Price Chief Accounting Officer | 335.0K | — | 443.8K | — | 307.6K | 14.9K | 1.10M | 40.30% | ↗ |
| 16 | 2022 | Mark J. Tarr President and Chief Executive Officer | 1.05M | — | 4.36M | 1.06M | 1.18M | 92.1K | 7.74M | 69.97% | ↗ |
| 17 | 2022 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.62M | 392.9K | 569.8K | 48.4K | 3.33M | 60.46% | ↗ |
| 18 | 2022 | Barbara A. Jacobsmeyer Chief Executive Officer, Home Health and Hospice | 375.0K | — | 1.58M | 382.7K | — | 37.6K | 2.38M | 82.63% | ↗ |
| 19 | 2022 | Patrick Darby Executive Vice President, General Counsel and Secretary | 550.0K | — | 765.0K | 185.2K | 395.0K | 10.3K | 1.91M | 49.87% | ↗ |
| 20 | 2022 | Elissa J. Charbonneau Chief Medical Officer | 415.0K | — | 481.1K | — | 198.7K | 16.8K | 1.11M | 43.28% | ↗ |
| 21 | 2022 | Andrew L. Price Chief Accounting Officer | 335.0K | — | 388.3K | — | 160.4K | 20.8K | 904.5K | 42.93% | ↗ |
| 22 | 2021 | Mark J. Tarr President and Chief Executive Officer | 1.05M | — | 4.19M | 1.03M | 1.92M | 66.9K | 8.25M | 63.20% | ↗ |
| 23 | 2021 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.56M | 382.1K | 912.5K | 37.5K | 3.59M | 54.06% | ↗ |
| 24 | 2021 | Barbara A. Jacobsmeyer Chief Executive Officer, Home Health and Hospice | 703.8K | — | 1.30M | 319.3K | 871.4K | 143.3K | 3.34M | 48.57% | ↗ |
| 25 | 2021 | Patrick Darby Executive Vice President, General Counsel and Secretary | 550.0K | — | 735.3K | 180.1K | 632.6K | 887.00 | 2.10M | 43.61% | ↗ |
| 26 | 2021 | April K. Anthony Former CEO, Home Health and Hospice | 550.0K | — | 735.3K | 180.1K | — | 2.0K | 1.47M | 62.38% | ↗ |
| 27 | 2021 | Elissa J. Charbonneau Chief Medical Officer | 375.0K | — | 417.8K | — | 287.6K | 13.9K | 1.09M | 38.18% | ↗ |
| 28 | 2020 | Mark J. Tarr President and Chief Executive Officer | 953.1K | — | 3.89M | 857.2K | 1.13M | 87.8K | 6.93M | 68.59% | ↗ |
| 29 | 2020 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 635.4K | — | 1.45M | 319.2K | 535.5K | 47.4K | 2.99M | 59.22% | ↗ |
| 30 | 2020 | Barbara A. Jacobsmeyer Chief Executive Officer, Home Health and Hospice | 620.0K | — | 1.21M | 266.7K | 497.3K | 27.0K | 2.62M | 56.37% | ↗ |
| 31 | 2020 | Barbara A. Jacobsmeyer Executive Vice President and President, Inpatient Hospitals | 620.0K | — | 1.21M | 266.7K | 497.3K | 27.0K | 2.62M | 56.37% | ↗ |
| 32 | 2020 | April K. Anthony Chief Executive Officer, Home Health and Hospice | 524.6K | — | 683.5K | 150.5K | 371.3K | 3.8K | 1.73M | 48.11% | ↗ |
| 33 | 2020 | April K. Anthony Former CEO, Home Health and Hospice | 524.6K | — | 683.5K | 150.5K | 371.3K | 3.8K | 1.73M | 48.11% | ↗ |
| 34 | 2020 | Patrick Darby Executive Vice President, General Counsel and Secretary | 524.6K | — | 683.5K | 150.5K | 371.3K | 1.8K | 1.73M | 48.16% | ↗ |
| 35 | 2019 | Mark J. Tarr President and Chief Executive Officer | 1.05M | — | 3.61M | 889.5K | 1.63M | 96.8K | 7.27M | 61.85% | ↗ |
| 36 | 2019 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.10M | 270.7K | 801.6K | 54.9K | 2.93M | 46.79% | ↗ |
| 37 | 2019 | April K. Anthony Chief Executive Officer, Home Health and Hospice | 347.0K | — | 1.91M | 100.7K | 173.5K | 2.9K | 2.53M | 79.33% | ↗ |
| 38 | 2019 | April K. Anthony Former CEO, Home Health and Hospice | 347.0K | — | 1.91M | 100.7K | 173.5K | 2.9K | 2.53M | 79.33% | ↗ |
| 39 | 2019 | Barbara A. Jacobsmeyer Chief Executive Officer, Home Health and Hospice | 650.0K | — | 892.1K | 220.0K | 700.5K | 26.2K | 2.49M | 44.68% | ↗ |
| 40 | 2019 | Barbara A. Jacobsmeyer Executive Vice President and President, Inpatient Hospitals | 650.0K | — | 892.1K | 220.0K | 700.5K | 26.2K | 2.49M | 44.68% | ↗ |
| 41 | 2019 | Patrick Darby Executive Vice President, General Counsel and Secretary | 550.0K | — | 647.1K | 159.5K | 555.7K | 2.9K | 1.92M | 42.12% | ↗ |
| 42 | 2018 | Mark J. Tarr President and Chief Executive Officer | 962.5K | — | 2.83M | 750.9K | 1.77M | 71.0K | 6.39M | 56.10% | ↗ |
| 43 | 2018 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.13M | 300.3K | 939.6K | 48.8K | 3.12M | 45.92% | ↗ |
| 44 | 2018 | Barbara A. Jacobsmeyer Executive Vice President and President, Inpatient Hospitals | 550.0K | — | 667.8K | 177.0K | 651.4K | 17.9K | 2.06M | 40.93% | ↗ |
| 45 | 2018 | Patrick Darby Executive Vice President, General Counsel and Secretary | 475.0K | — | 576.9K | 152.9K | 507.1K | 3.0K | 1.71M | 42.55% | ↗ |
| 46 | 2018 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 436.4K | — | 326.9K | 12.2K | 1.12M | 38.95% | ↗ |
| 47 | 2017 | Mark J. Tarr President and Chief Executive Officer | 900.0K | — | 2.28M | 540.2K | 1.17M | 46.9K | 4.93M | 57.11% | ↗ |
| 48 | 2017 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 700.0K | — | 1.18M | 280.1K | 773.0K | 36.9K | 2.97M | 49.18% | ↗ |
| 49 | 2017 | Patrick Darby Executive Vice President, General Counsel and Secretary | 475.0K | — | 601.1K | 142.6K | 368.6K | 1.2K | 1.59M | 46.82% | ↗ |
| 50 | 2017 | Barbara A. Jacobsmeyer Executive Vice President and President, Inpatient Hospitals | 450.0K | — | 569.5K | 135.1K | 409.2K | 10.1K | 1.57M | 44.76% | ↗ |
| 51 | 2017 | Barbara A. Jacobsmeyer Executive Vice President of Operations | 450.0K | — | 569.5K | 135.1K | 409.2K | 10.1K | 1.57M | 44.76% | ↗ |
| 52 | 2017 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 454.8K | — | 268.9K | 14.6K | 1.08M | 41.98% | ↗ |
| 53 | 2016 | Jay Grinney Former President and Chief Executive Officer | 1.00M | — | 4.05M | 1.10M | 948.8K | 192.1K | 7.29M | 70.65% | ↗ |
| 54 | 2016 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 570.8K | — | 1.07M | 651.5K | 440.2K | 32.0K | 2.77M | 62.33% | ↗ |
| 55 | 2016 | Mark J. Tarr President and Chief Executive Officer | 645.8K | — | 921.2K | 250.0K | 524.2K | 39.2K | 2.38M | 49.20% | ↗ |
| 56 | 2016 | Patrick Darby Executive Vice President, General Counsel and Secretary | 429.3K | 100.0K | 825.1K | 142.5K | 247.9K | 130.00 | 1.74M | 55.45% | ↗ |
| 57 | 2016 | Barbara A. Jacobsmeyer Executive Vice President and President, Inpatient Hospitals | 375.0K | — | 518.2K | — | 213.5K | 9.9K | 1.12M | 46.41% | ↗ |
| 58 | 2016 | Barbara A. Jacobsmeyer Executive Vice President of Operations | 375.0K | — | 518.2K | — | 213.5K | 9.9K | 1.12M | 46.41% | ↗ |
| 59 | 2016 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 397.3K | — | 196.4K | 17.6K | 956.3K | 41.55% | ↗ |
| 60 | 2015 | Jay Grinney Former President and Chief Executive Officer | 1.00M | — | 4.67M | 1.07M | 808.0K | 267.3K | 7.82M | 73.45% | ↗ |
| 61 | 2015 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 4.67M | 1.07M | 808.0K | 267.3K | 7.82M | 73.45% | ↗ |
| 62 | 2015 | Mark J. Tarr President and Chief Executive Officer | 625.0K | — | 1.06M | 244.2K | 454.0K | 73.4K | 2.46M | 53.10% | ↗ |
| 63 | 2015 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 625.0K | — | 1.06M | 244.2K | 454.0K | 73.4K | 2.46M | 53.10% | ↗ |
| 64 | 2015 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 668.2K | 153.8K | 357.5K | 56.9K | 1.76M | 46.66% | ↗ |
| 65 | 2015 | John P. Whittington Executive Vice President, General Counsel and Secretary | 527.0K | — | 670.8K | 154.4K | 255.5K | 50.0K | 1.66M | 49.78% | ↗ |
| 66 | 2015 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 362.8K | — | 161.6K | 25.8K | 895.2K | 40.52% | ↗ |
| 67 | 2014 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 4.15M | 999.7K | 870.0K | 375.8K | 7.40M | 69.65% | ↗ |
| 68 | 2014 | Jay Grinney Former President and Chief Executive Officer | 1.00M | — | 4.15M | 999.7K | 870.0K | 375.8K | 7.40M | 69.65% | ↗ |
| 69 | 2014 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 620.8K | — | 997.1K | 239.9K | 435.0K | 97.8K | 2.39M | 51.75% | ↗ |
| 70 | 2014 | Mark J. Tarr President and Chief Executive Officer | 620.8K | — | 997.1K | 239.9K | 435.0K | 97.8K | 2.39M | 51.75% | ↗ |
| 71 | 2014 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 654.4K | 157.4K | 346.5K | 85.6K | 1.77M | 45.90% | ↗ |
| 72 | 2014 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 656.8K | 158.1K | 278.3K | 67.7K | 1.69M | 48.28% | ↗ |
| 73 | 2014 | John P. Whittington Executive Vice President, General Counsel and Secretary | 527.0K | — | 656.8K | 158.1K | 278.3K | 67.7K | 1.69M | 48.28% | ↗ |
| 74 | 2014 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 358.2K | — | 153.4K | 33.7K | 890.2K | 40.23% | ↗ |
| 75 | 2013 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 3.85M | 1.03M | 1.28M | 182.5K | 7.36M | 66.46% | ↗ |
| 76 | 2013 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 600.0K | — | 693.7K | 186.2K | 469.7K | 53.8K | 2.00M | 43.92% | ↗ |
| 77 | 2013 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 607.0K | 162.9K | 417.3K | 45.2K | 1.76M | 43.81% | ↗ |
| 78 | 2013 | John P. Whittington Executive Vice President, General Counsel and Secretary | 527.0K | — | 609.3K | 163.5K | 409.4K | 42.5K | 1.75M | 44.12% | ↗ |
| 79 | 2013 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 609.3K | 163.5K | 409.4K | 42.5K | 1.75M | 44.12% | ↗ |
| 80 | 2013 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 609.3K | 163.5K | 409.4K | 42.5K | 1.75M | 44.12% | ↗ |
| 81 | 2013 | Cheryl B. Levy Chief Human Resources Officer | 345.0K | — | 332.2K | — | 218.9K | 17.9K | 914.1K | 36.34% | ↗ |
| 82 | 2012 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 3.69M | 1.58M | 1.30M | 105.0K | 7.67M | 68.67% | ↗ |
| 83 | 2012 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 588.2K | — | 1.69M | 250.0K | 473.5K | 32.7K | 3.03M | 63.93% | ↗ |
| 84 | 2012 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 1.14M | 250.0K | 408.0K | 21.2K | 2.34M | 59.24% | ↗ |
| 85 | 2012 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 694.6K | 250.0K | 412.7K | 31.0K | 1.92M | 49.32% | ↗ |
| 86 | 2012 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 694.6K | 250.0K | 412.7K | 31.0K | 1.92M | 49.32% | ↗ |
| 87 | 2012 | Cheryl B. Levy Chief Human Resources Officer | 339.2K | — | 424.3K | — | 214.9K | 13.5K | 991.9K | 42.78% | ↗ |
| 88 | 2011 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 3.49M | 1.46M | 1.59M | 148.1K | 7.69M | 64.42% | ↗ |
| 89 | 2011 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 3.49M | 1.46M | 1.59M | 148.1K | 7.69M | 64.42% | ↗ |
| 90 | 2011 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 639.7K | 264.8K | 505.3K | 37.1K | 1.97M | 45.82% | ↗ |
| 91 | 2011 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 639.7K | 264.8K | 505.3K | 37.1K | 1.97M | 45.82% | ↗ |
| 92 | 2011 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 521.0K | — | 639.7K | 264.8K | 504.3K | 30.2K | 1.96M | 46.15% | ↗ |
| 93 | 2011 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 521.0K | — | 639.7K | 264.8K | 504.3K | 30.2K | 1.96M | 46.15% | ↗ |
| 94 | 2011 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 639.7K | 264.8K | 503.4K | 8.3K | 1.94M | 46.60% | ↗ |
| 95 | 2011 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 525.0K | — | 639.7K | 264.8K | 503.4K | 8.3K | 1.94M | 46.60% | ↗ |
| 96 | 2011 | Dexanne B. Clohan, M.D. Chief Medical Officer | 320.3K | — | 345.3K | — | 245.4K | 16.4K | 927.4K | 37.24% | ↗ |
| 97 | 2011 | Cheryl B. Levy Chief Human Resources Officer | — | — | — | — | — | — | — | — | ↗ |
| 98 | 2010 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 2.81M | 1.28M | 1.44M | 112.5K | 6.64M | 61.58% | ↗ |
| 99 | 2010 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 2.81M | 1.28M | 1.44M | 112.5K | 6.64M | 61.58% | ↗ |
| 100 | 2010 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 479.3K | — | 623.4K | 284.5K | 411.5K | 7.2K | 1.81M | 50.28% | ↗ |
| 101 | 2010 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 479.3K | — | 623.4K | 284.5K | 411.5K | 7.2K | 1.81M | 50.28% | ↗ |
| 102 | 2010 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 503.2K | 229.7K | 455.6K | 21.9K | 1.74M | 42.18% | ↗ |
| 103 | 2010 | Dexanne B. Clohan, M.D. Chief Medical Officer | 320.3K | — | 286.1K | — | 221.9K | 7.5K | 835.9K | 34.23% | ↗ |
| 104 | 2010 | Edmund M. Fay Treasurer and Senior Vice President (acting principal financial officer) | 257.5K | 50.0K | 320.9K | — | 178.4K | 13.3K | 820.1K | 39.13% | ↗ |
| 105 | 2010 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 345.2K | — | 100.0K | — | 304.1K | 8.3K | 757.6K | 13.20% | ↗ |
| 106 | 2010 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | 345.2K | — | 100.0K | — | 304.1K | 8.3K | 757.6K | 13.20% | ↗ |
| 107 | 2010 | Cheryl B. Levy Chief Human Resources Officer | — | — | — | — | — | — | — | — | ↗ |
| 108 | 2009 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 2.06M | 1.13M | 1.79M | 58.5K | 6.04M | 52.83% | ↗ |
| 109 | 2009 | John L. Workman Executive Vice President and Chief Financial Officer | 509.5K | 250.0K | 634.1K | 342.5K | — | 359.7K | 2.10M | 46.60% | ↗ |
| 110 | 2009 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 527.0K | — | 370.6K | 202.7K | 567.6K | 30.3K | 1.70M | 33.76% | ↗ |
| 111 | 2009 | Mark J. Tarr Executive Vice President, Operations | 429.3K | 175.0K | 370.6K | 202.7K | 463.7K | 5.7K | 1.65M | 34.81% | ↗ |
| 112 | 2009 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 429.3K | 175.0K | 370.6K | 202.7K | 463.7K | 5.7K | 1.65M | 34.81% | ↗ |
| 113 | 2009 | Dexanne B. Clohan, M.D. Chief Medical Officer and Senior Vice President | 318.8K | — | 196.0K | — | 272.3K | 9.2K | 796.3K | 24.61% | ↗ |
| 114 | 2009 | Dexanne B. Clohan, M.D. Chief Medical Officer | 318.8K | — | 196.0K | — | 272.3K | 9.2K | 796.3K | 24.61% | ↗ |
| 115 | 2009 | Edmund M. Fay Treasurer and Senior Vice President (acting principal financial officer) | 256.2K | — | 205.9K | — | 217.6K | 12.9K | 692.6K | 29.72% | ↗ |
| 116 | 2009 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 117 | 2008 | Jay Grinney President and Chief Executive Officer | 1.00M | — | 2.38M | 1.23M | 1.37M | 27.9K | 6.01M | 60.04% | ↗ |
| 118 | 2008 | John L. Workman Executive Vice President and Chief Financial | 608.2K | — | 714.8K | 380.9K | 569.1K | 147.8K | 2.42M | 45.26% | ↗ |
| 119 | 2008 | John L. Workman Executive Vice President and Chief Financial Officer | 608.2K | 125.0K | 443.8K | 465.9K | 569.1K | 22.8K | 2.23M | 40.71% | ↗ |
| 120 | 2008 | John P. Whittington Executive Vice President, General Counsel and | 525.8K | — | 466.8K | 176.8K | 403.0K | 20.8K | 1.59M | 40.39% | ↗ |
| 121 | 2008 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 525.8K | — | 310.6K | 326.6K | 403.0K | 20.8K | 1.59M | 40.15% | ↗ |
| 122 | 2008 | Mark J. Tarr Executive Vice President, Operations | 426.8K | 90.0K | 310.6K | 326.6K | 328.3K | 5.0K | 1.49M | 42.84% | ↗ |
| 123 | 2008 | Mark J. Tarr Executive Vice President and Chief Operating Officer | 426.8K | 90.0K | 310.6K | 326.6K | 328.3K | 5.0K | 1.49M | 42.84% | ↗ |
| 124 | 2008 | Dexanne B. Clohan, M.D. Chief Medical Officer and Senior Vice President | 306.6K | 76.8K | 178.4K | — | 198.8K | 13.8K | 774.4K | 23.04% | ↗ |
| 125 | 2008 | Dexanne B. Clohan, M.D. Chief Medical Officer | 306.6K | 76.8K | 178.4K | — | 198.8K | 13.8K | 774.4K | 23.04% | ↗ |
| 126 | 2008 | Edmund M. Fay Treasurer and Senior Vice President (acting principal financial officer) | — | — | — | — | — | — | — | — | ↗ |
| 127 | 2008 | Douglas E. Coltharp Executive Vice President and Chief Financial Officer | — | — | — | — | — | — | — | — | ↗ |
| 128 | 2007 | Jay Grinney President and Chief Executive Officer | 996.1K | — | 3.16M | 1.52M | 1.12M | 23.6K | 6.82M | 68.64% | ↗ |
| 129 | 2007 | Michael D. Snow Executive Vice President and Chief Operating | 333.8K | — | 377.1K | 430.7K | 275.9K | 1.49M | 2.91M | 27.78% | ↗ |
| 130 | 2007 | John L. Workman Executive Vice President and Chief Financial Officer | 579.1K | 131.3K | 725.5K | 258.1K | 463.6K | 7.8K | 2.17M | 45.42% | ↗ |
| 131 | 2007 | John L. Workman Executive Vice President and Chief Financial | 579.1K | — | 465.6K | 354.7K | 463.6K | 139.0K | 2.00M | 40.97% | ↗ |
| 132 | 2007 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 516.7K | — | 451.1K | 206.5K | 318.9K | 7.8K | 1.50M | 43.81% | ↗ |
| 133 | 2007 | John P. Whittington Executive Vice President, General Counsel and Corporate Secretary | 516.7K | — | 180.8K | 73.6K | 318.9K | 7.8K | 1.10M | 23.17% | ↗ |
| 134 | 2007 | Mark J. Tarr Executive Vice President, Operations | 366.6K | 85.1K | 139.1K | 206.5K | 242.8K | 3.2K | 1.04M | 33.13% | ↗ |
| 135 | 2007 | John Markus Executive Vice President and Chief Compliance | 245.8K | — | 69.7K | 148.2K | — | 265.9K | 729.7K | 29.87% | ↗ |
| 136 | 2007 | Dexanne B. Clohan, M.D. Chief Medical Officer and Senior Vice President | — | — | — | — | — | — | — | — | ↗ |
| 137 | 2007 | Edmund M. Fay Treasurer and Senior Vice President (acting principal financial officer) | — | — | — | — | — | — | — | — | ↗ |
| 138 | 2006 | Jay Grinney President and Chief Executive Officer | 981.2K | — | 503.5K | 2.66M | 765.1K | 25.2K | 4.93M | 64.09% | ↗ |
| 139 | 2006 | Jay Grinney President and Chief Executive Officer | 980.1K | — | 150.8K | 711.6K | 765.1K | 25.2K | 2.63M | 32.76% | ↗ |
| 140 | 2006 | Michael D. Snow Executive Vice President and Chief Operating | 642.6K | — | 752.4K | 408.8K | 463.5K | 5.9K | 2.27M | 51.08% | ↗ |
| 141 | 2006 | John L. Workman Executive Vice President and Chief Financial | 518.7K | — | 459.3K | 283.9K | 428.9K | 9.8K | 1.70M | 43.70% | ↗ |
| 142 | 2006 | Michael D. Snow Executive Vice President and Chief Operating Officer | 642.6K | — | 150.8K | 102.5K | 463.5K | 5.9K | 1.37M | 18.55% | ↗ |
| 143 | 2006 | John L. Workman Executive Vice President and Chief Financial Officer | 517.8K | — | 82.9K | 80.5K | 428.9K | 9.8K | 1.12M | 14.60% | ↗ |
| 144 | 2006 | Mark J. Tarr Executive Vice President, Operations | 336.0K | — | 219.8K | 186.1K | 206.5K | 4.5K | 953.0K | 42.60% | ↗ |
| 145 | 2006 | John Markus Executive Vice President and Chief Compliance | 387.6K | — | 142.9K | 185.2K | 212.9K | 9.2K | 937.9K | 34.99% | ↗ |
| 146 | 2006 | John Markus Executive Vice President and Chief Compliance Officer | 387.6K | — | 45.2K | 47.6K | 212.9K | 9.2K | 702.6K | 13.21% | ↗ |
| 147 | 2006 | James C. Foxworthy | 296.5K | — | 45.2K | 47.6K | 95.8K | 213.1K | 698.3K | 13.30% | ↗ |
| 148 | 2006 | Mark J. Tarr Executive Vice President, Operations | 335.4K | — | 45.2K | 43.9K | 206.5K | 4.5K | 635.6K | 14.03% | ↗ |
| 149 | 2006 | Dexanne B. Clohan, M.D. Chief Medical Officer and Senior Vice President | — | — | — | — | — | — | — | — | ↗ |
| 150 | 2006 | John P. Whittington Executive Vice President, General Counsel and | — | — | — | — | — | — | — | — | ↗ |
| 151 | 2004 | Jay Grinney President and Chief Executive Officer | 571.2K | — | 521.0K | 1.00M | — | 50.8K | 1.14M | 133.08% | ↗ |
| 152 | 2004 | Michael D. Snow Executive Vice President and Chief Operating Officer | 294.7K | 100.0K | 450.0K | 65.0K | — | 266.6K | 1.11M | 46.34% | ↗ |
| 153 | 2004 | John Markus Executive Vice President and Chief Compliance Officer | 327.5K | 70.0K | 132.0K | — | — | 232.9K | 762.3K | 17.32% | ↗ |
| 154 | 2004 | John L. Workman Executive Vice President and Chief Financial Officer | 127.2K | 75.0K | 138.9K | — | — | 11.6K | 352.6K | 39.38% | ↗ |
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Mark J. Tarr | Chief Executive Officer, President & Director | 4M | male |
| Douglas E. Coltharp | Executive Vice President & Chief Financial Officer | 2M | male |
| John Patrick Darby | Executive Vice President, General Counsel & Corporate Secretary | 2M | male |
| Patrick W. Tuer | EVP & Chief Operating Officer | 1M | male |
| Elissa Joy Charbonneau | Chief Medical Officer | 926.1K | female |
| Andrew L. Price | Senior Vice President & Chief Accounting Officer | 656.3K | male |
| Dawn Rock | Chief Compliance Officer | — | female |
| Mark Miller | Senior Vice President of Investor Relations & Strategic Planning | — | male |
| Anthony A. Hernandez | Chief Human Resources Officer | — | male |
| Rusty Yeager | Chief Information Officer & Senior Vice President | — | male |
No Senate trading activity found for this company.
| Transaction Date | Disclosed | Representative | District | Owner | Type | Amount | Link |
|---|---|---|---|---|---|---|---|
| 2025-07-22 | 2025-08-13 | Lisa McClain | MI09 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2023-03-14 | 2023-04-07 | Ro Khanna | CA17 | Spouse | Sale | $1,001 - $15,000 | ↗ |
| 2022-12-06 | 2023-01-03 | Ro Khanna | CA17 | Spouse | Purchase | $1,001 - $15,000 | ↗ |
| 2021-02-16 | 2021-03-16 | Peter Meijer | MI03 | — | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-08-27 | 2020-10-07 | Susie Lee | NV03 | Joint | Sale (Full) | $1,001 - $15,000 | ↗ |
| 2020-05-19 | 2020-06-15 | Susie Lee | NV03 | Joint | Purchase | $1,001 - $15,000 | ↗ |
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EHC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
